WASHINGTON, D.C. - ( Mealeys ) In a divided ruling, the Federal Circuit U.S.
Court of Appeals today [August 16th] reversed a New York federal judge's determination that
composition claims related to isolated DNA molecules are patent-ineligible
products of nature and scientific principles pursuant...
D.C. - ( Mealey's ) Less than a year after it returned to the Federal Circuit U.S. Court of
Appeals a patent lawsuit over diagnostic test kits for determining hereditary
risk of breast and ovarian cancer, the U.S. Supreme Court on Friday announced
it will again take up the case (...